ImpediMed Ltd.

ImpediMed Ltd.
Stock Exchange Other OTC
EPS
$0.05
Market Cap
$48.11 M
Shares Outstanding
378.91 M
Public Float
-
ImpediMed Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.06
Market Cap
AUD68.36 M
Shares Outstanding
379.8 M
Public Float
334.67 M

Profile

Address
50 Parker Court
Pinkenba Queensland (QLD) 4008
Australia
Employees -
Website http://www.impedimed.com
Updated 07/08/2019
ImpediMed Ltd. engages in the development and distribution of medical devices using bioimpedance spectroscopy technologies for use in the non-invasive clinical assessment and monitoring of human disorders and diseases. It operates through the Medical and Test and Measurement segments. The Medical segment supplies non-invasive medical devices to two under-served markets: aiding in the subclinical assessment of individuals at risk of secondary lymphoedema; and the monitoring of body composition and hydration.

Financials

View All

Scott R. Ward
Chairman
Richard Carreon
President, CEO, Executive Director & MD